After the books closed: the quarter's biggest news happened too late to be in the numbers
The model's full reasoning — Q1 2023 call → NOThe question asks whether management reports that the most important positive developments happened so late in the reported period or shortly after it ended that the results contain little or none of their effect, with management itself marking the timing. Let me analyze the transcript for this pattern. Key elements to look for: 1. Late-breaking, concrete positive events - specific developments that occurred near the end of the period or after quarter-end 2. Management treats them as the real story the numbers missed Looking at the transcript, Ted Karkus discusses several business lines: - Manufacturing facility (growing ~100% per year, demand for $25M revenues next year) - Nebula Genomics (waiting for validations, will build out in second half of this year) - Esophageal cancer test (commercialization early next year) - Linebacker cancer compound (preclinical, positive results) - COVID testing (slowing) The key question is whether management points to specific late-breaking events that occurred near the end of the period or after quarter-end, and whether management says the reported results don't reflect them. Looking at the transcript more carefully: For Nebula Genomics: "We are waiting for the validations, which will take another couple of months and then we will start to build out those businesses in the second half of this year with our whole genome sequencing business. Right now, we process our specimens abroad. We cannot aggressively build a B2B business until we are processing these specimens in-house. So we anticipate building a very nice Nebula Genomics business the second half of this year, particularly in the fourth quarter." This is about future expectations, not late-breaking events that already occurred. For the manufacturing facility: "we have demand for at least $25 million of revenues next year in 2024, and we're just constrained by how quickly we can build out the additional capacity, which is going to take this year to do so. So right now, our revenues are running up almost a 100% year over year." This is about ongoing growth, not a specific late-breaking event. For the esophageal cancer test: "we are looking to commercialize this next year" - future.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASM | Avino Silver & Gold Mines Ltd. | Q4 2023 | 2024-03-21 | C+ |
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| NBTX | Nanobiotix S.A. | Q2 2023 | 2023-09-27 | D |
| SWBI | Smith & Wesson Brands, Inc. | Q1 2023 | 2022-09-08 | C+ |
| YMM | Full Truck Alliance Co. Ltd. | Q2 2022 | 2022-08-25 | C+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| BFIN | BankFinancial Corporation | Q1 2022 | 2022-05-06 | A |
| RNW | ReNew Energy Global Plc | Q2 2022 | 2021-11-18 | C |
| BFI | BurgerFi International, Inc. | Q3 2021 | 2021-11-12 | C |
| LIND | Lindblad Expeditions Holdings, Inc. | Q2 2017 | 2017-08-06 | C |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
OPK · Q1 2022 → YESThe question is: Does management report that the MOST IMPORTANT POSITIVE DEVELOPMENTS of the period happened SO LATE IN THE REPORTED PERIOD, OR SHORTLY AFTER IT ENDED, that the results being presented...YES The transcript shows management treating the ModeX acquisition (announced and closed on the call date, May 9) and the Sema4/GeneDx deal (closed April 29) as major positive developments that occurred after the Q1 period ended. These are framed as key steps toward unlocking value and are highlighted as the "exciting announcement" that changed the call format.
RNW · Q2 2022 → YESThe question is: Does management report that the MOST IMPORTANT POSITIVE DEVELOPMENTS of the period happened SO LATE IN THE REPORTED PERIOD, OR SHORTLY AFTER IT ENDED, that the results being presented...YES The transcript shows management explicitly marking the timing of key positive developments: 400 MW commissioned "since the end of the quarter" (bringing operating capacity to 7 GW today, with another 400 MW scheduled "over the next couple of weeks"), plus the completed Telangana acquisition adding 260 MW.
ASM · Q4 2023 → YESThe question is: Does management report that the MOST IMPORTANT POSITIVE DEVELOPMENTS of the period happened SO LATE IN THE REPORTED PERIOD, OR SHORTLY AFTER IT ENDED, that the results being presented...